Developing an algorithm to identify people with Chronic Obstructive Pulmonary Disease (COPD) using administrative data
Margrethe Smidth, Ineta Sokolowski, Lone Kærsvang, Peter Vedsted, Margrethe Smidth, Ineta Sokolowski, Lone Kærsvang, Peter Vedsted
Abstract
Background: An important prerequisite for the Chronic Care Model is to be able to identify, in a valid, simple and inexpensive way, the population with a chronic condition that needs proactive and planned care. We investigated if a set of administrative data could be used to identify patients with Chronic Obstructive Pulmonary Disease in a Danish population.
Methods: Seven general practices were asked to identify patients with known Chronic Obstructive Pulmonary Disease in their practices. For the 266 patients (population A), we used administrative data on hospital admissions for lung-related diagnoses, redeemed prescriptions for lung-diseases drugs and lung- function tests combined to develop an algorithm that identified the highest proportion of patients with Chronic Obstructive Pulmonary Disease with the fewest criteria involved. We tested nine different algorithms combining two to four criteria. The simplest algorithm with highest positive predictive value identified 532 patients (population B); with possible diagnosis of Chronic Obstructive Pulmonary Disease in five general practices. The doctors were asked to confirm the diagnosis. The same algorithm identified 2,895 patients whom were asked to confirm their diagnosis (population C).
Results: In population A the chosen algorithm had a positive predictive value of 72.2 % and three criteria: a) discharged patients with a chronic lung-disease diagnosis at least once during the preceding 5 years; or b) redeemed prescription of lung-medication at least twice during the preceding 12 months; or c) at least two spirometries performed at different dates during the preceding 12 months. In population B the positive predictive value was 65.0 % [60.8;69.1 %] and the sensitivity 44.8 % [41.3;48.4 %)] when the "uncertain" were added to where doctors agreed with the diagnosis. For the 1,984 respondents in population C, the positive predictive value was 72.9 % [70.8;74.8 %] and the sensitivity 29.7 % [28.4;31.0 %].
Conclusions: An algorithm based on administrative data has been developed and validated with sufficient positive predictive value to be used as a tool for identifying patients with Chronic Obstructive Pulmonary Disease. Some of the identified patients had other chronic lung-diseases (asthma). The algorithm should mostly be regarded as a tool for identifying chronic lung-disease and further development of the algorithm is needed.
Trial registration: www.clinicaltrials.gov (NCT01228708).
Figures
References
- Wagner EH, Austin BT, Davis C, Hindmarsh M, Schaefer J, Bonomi A. Improving chronic illness care: translating evidence into action. Health Aff (Millwood) 2001;20:64–78. doi: 10.1377/hlthaff.20.6.64.
- Nolte E, Knai C, McKee M. Managing Chronic Conditions - experience in eight countries. World Health Organization, on behalf of the European Observatory on Health Systems and Policies. 2008.
- Groves T, Wagner EH. High quality care for people with chronic diseases. BMJ. 2005;330:609–610. doi: 10.1136/bmj.330.7492.609.
- Bodenheimer T, Wagner EH, Grumbach K. Improving primary care for patients with chronic illness. JAMA. 2002;288:1775–1779. doi: 10.1001/jama.288.14.1775.
- Wagner EH. Chronic disease management: what will it take to improve care for chronic illness? Eff Clin Pract. 1998;1:2–4.
- Steuten L, Vrijhoef B. van MF, Wesseling GJ, Spreeuwenberg C: Evaluation of a regional disease management programme for patients with asthma or chronic obstructive pulmonary disease. Int J Qual Health Care. 2006;18:429–436. doi: 10.1093/intqhc/mzl052.
- National Board of Health, Denmark. Disease Management Programs for Chronic Disease -Generic Model and Model for diabetes. National Board of Health; 2008. In Danish.
- Løkke A, Lange P, Scharling H, Fabricius P, Vestbo J. Developing COPD: a 25 year follow up study of the general population. Thorax. 2006;61:935–9. doi: 10.1136/thx.2006.062802.
- Hansen JG. The prevalence of Chronic Obstructive Pulmonary Disease. Ugeskr Laeger. 2009;171:2986–8. In Danish.
- Ham C. Learning from Kaiser Permanente, a progress report. Department of Health, London; 2003.
- Pedersen CB. The Danish Civil Registration System. Scand J Public Health. 2011;39:22–25. doi: 10.1177/1403494810387965.
- Sahl Andersen J, de Fine Olivarius N, Krasnik A. The Danish National Health Service Register. Scand J Public Health. 2011;39:34–37. doi: 10.1177/1403494810394718.
- Wallach Kildemoes H, Sorensen HT, Hallas J. The Danish National Prescription Registry. Scand J Public Health. 2011;39:38–41. doi: 10.1177/1403494810394717.
- Pauwels RA, Buist AS, Ma P, Jenkins CR, Hurd SS. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: National Heart, Lung, and Blood Institute and World Health Organization Global Initiative for Chronic Obstructive Lung Disease (GOLD): executive summary. Respir Care. 2001;46:798–825.
- Hansen JG, Pedersen L, Overvad K, Omland O, Jensen HK, Sorensen HT. Prevalence of chronic obstructive pulmonary disease–secondary publication. Ugeskr Laeger. 2009;171:2986–2988.
- Sorensen HT. SFEE: Research in the Danish health service system: completeness and validity of prescription data, illustrated by analysis of utilization of oral anticoagulants. Int J Risk Saf Med. 1995;7:41–14.
- Hallas J. Drug utilization statistics for individual-level pharmacy dispensing data. Pharmacoepidemiol Drug Saf. 2005;14:455–463. doi: 10.1002/pds.1063.
- Wogelius P, Poulsen S, Sorensen HT. Validity of parental-reported questionnaire data on Danish children's use of asthma-drugs: a comparison with a population-based prescription database. Eur J Epidemiol. 2005;20:17–22. doi: 10.1007/s10654-004-1501-6.
- Moth G, Vedsted P, Schiotz P. Identification of asthmatic children using prescription data and diagnosis. Eur J Clin Pharmacol. 2007;63:605–611. doi: 10.1007/s00228-007-0286-4.
- Rabe KF, Hurd S, Anzueto A, Barnes PJ, Buist SA, Calverley P, Fukuchi Y, Jenkins C, Rodriguez-Roisin R. van WC, Zielinski J: Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med. 2007;176:532–555. doi: 10.1164/rccm.200703-456SO.
- Mapel DW, Petersen H, Roberts MH, Hurley JS, Frost FJ, Marton JP. Can outpatient pharmacy data identify persons with undiagnosed COPD? Am J Manag Care. 2010;16:505–512.
- To T, Dell S, Dick PT, Cicutto L, Harris JK, MacLusky IB, Tassoudji M. Case verification of children with asthma in Ontario. Pediatr Allergy Immunol. 2006;17:69–76. doi: 10.1111/j.1399-3038.2005.00346.x.
- Thomsen RW, Lange P, Hellquist B, Frausing E, Bartels PD, Krog BR, Hansen AM, Buck D, Bunk AE. Validity and underrecording of diagnosis of COPD in the Danish National Patient Registry. Respir Med. 2011;105:1063–1068. doi: 10.1016/j.rmed.2011.01.012.
- Gruffydd-Jones K, Richman J, Jones RC, Wang X. A pilot study of identification and case management of high-risk COPD patients in a general practice. Fam Pract. 2010;27:494–498. doi: 10.1093/fampra/cmq045.
- National Board of Health. COPD- Chronic Obstructive Pulmonary Disease: Recommendations for tracking, following, treating and rehabilitate. 2007. p. 2. In Danish.
- Doherty DE, Chapman KR, Martinez FJ, Belfer MH. The value of early diagnosis for effective management of chronic obstructive pulmonary disease. J Fam Pract. 2007;56:S1–24.
- Pauwels RA, Rabe KF. Burden and clinical features of chronic obstructive pulmonary disease (COPD) Lancet. 2004;364:613–620. doi: 10.1016/S0140-6736(04)16855-4.
Source: PubMed